A big-hearted message

By afaqs! news bureau , afaqs!, New Delhi | In Advertising | February 24, 2015
Ranbaxy Labs and APICON jointly conducted an on-ground campaign in which they formed the largest human heart, with doctors and other representatives, making it into the Guinness Book of World Records.

Ranbaxy Laboratories and APICON 2015 (70th Annual Conference of Association of Physicians of India) recently created a Guinness World Record for making the largest human image of a heart in Gurgaon, Haryana, India.

The two assembled 982 people (consisting of doctors and Ranbaxy employees) to form a human heart. The formation of the human heart was achieved in one hour and 15 minutes. The participants wore t-shirts and caps of distinct colors to bring out the correct anatomical representation of this central body organ.

Formation of Human Heart campaign

The idea behind the actiavtion was to spread awareness on the need for a proactive emphasis on preventive healthcare and raising awareness about heart diseases in India.

The creation beat the world record for the largest image of a human organ ever formed by a group of humans assembled together. The earlier record was set on February 20, 2014, in Liverpool, UK, when 687 people came together to form the image of the largest human brain on World Encephalitis Day.

On the milestone achievement, Lucia Sinigagliesi, adjudicator, Guinness World Records, says, "It is good to see the enthusiasm of the crowd during the event, and I wish to congratulate Ranbaxy and APICON for the successful record attempt. Initiatives taken to spread awareness about the importance of physical exercise is a good message for the public. I appreciate team Ranbaxy's efforts in this endeavour."

Rajeev Sibal, vice president and head, India region, Ranbaxy, says, "The event would be truly successful when each one of us take the 30-minute exercise challenge daily and spread the message to more and more number of people."

Ashok K Taneja, organising secretary, APICON 2015, says, "When the entire disease management is shifting towards prevention, mass initiatives like these would help to create more and more awareness on the importance of exercise and fitness, which can avoid many diseases."

Indians have genetic predisposition to the Coronary Artery Disease (CAD). Changing lifestyle, urbanisation, unhealthy food habits, decreasing physical activity, rising stress levels and rampant obesity have made the problem more severe. As a result, the country has seen a significant increase in the number of heart disease patients over the past 20 years. Worse, the average age of a heart patient in India is in the early fifties, compared to seventies in developed nations like the US.

The 70th APICON was organised in Gurgaon between February 19 and 22, 2015. The theme this year focused on 'Optimising Patient Care'. The event was significant as it marked the platinum jubilee of the long-standing conference.

Ranbaxy Laboratories produces a wide range of quality, affordable generic medicines. The company has further strengthened its focus on generics research, and is increasingly working on more complex and specialty areas. Ranbaxy serves its customers in over 150 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 43 countries and manufacturing operations in eight countries.

Ranbaxy is a member of the Daiichi Sankyo Group. Through strategic in-licensing opportunities and its hybrid business model with Daiichi Sankyo, a leading global pharma innovator headquartered in Tokyo, Japan, Ranbaxy is introducing many innovator products in markets around the world, where it has a strong presence.